GB

Gregory G. Burrows

OU Oregon Health & Science University: 12 patents #14 of 725Top 2%
DA Department Of Veterans Affairs: 7 patents #7 of 615Top 2%
UA US Dept of Veterans Affairs: 1 patents #175 of 605Top 30%
📍 Portland, OR: #1,483 of 9,213 inventorsTop 20%
🗺 Oregon: #3,599 of 28,073 inventorsTop 15%
Overall (All Time): #415,745 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
10316075 Recombinant polypeptides comprising MHC class II α1 domains Arthur A. Vandenbark, Roberto Meza-Romero, Gil Benedek 2019-06-11
9926360 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells Arthur A. Vandenbark 2018-03-27
9492536 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Patricia D. Hurn, Arthur A. Vandenbark 2016-11-15
9359425 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Arthur A. Vandenbark 2016-06-07
9243051 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells Arthur A. Vandenbark 2016-01-26
9050279 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Patricia D. Hurn, Arthur A. Vandenbark 2015-06-09
8895018 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Arthur A. Vandenbark 2014-11-25
8491913 Compositions and methods using recombinant MHC molecules for the treatment of stroke Halina Offner, Arthur A. Vandenbark, Patricia D. Hurn 2013-07-23
8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells Arthur A. Vandenbark 2013-02-19
7265218 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Arthur A. Vandenbark 2007-09-04
6815171 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Arthur A. Vandenbark 2004-11-09
6270772 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells Arthur A. Vandenbark 2001-08-07